1. Introduction
At Narvs Pharma Private Limited (referred to herein as "Narvs Pharma," "we," "us," or "our"), we understand how critical privacy and security are to our clinical partners, licensed pharmacies, health units, and corporate clients. This Privacy Policy details how we collect, process, manage, and safeguard any personal or corporate information you share with us when you navigate our wholesale trading platform, communicate with our sales department, or inquire about pharmaceutical distribution services.
Unless explicitly stated otherwise in a separate written agreement, this policy governs the interaction of all trade visitors, purchasing entities, contract manufacturers, and corporate agents who access our wholesale product listings or submit business inquiries as described in our Terms and Conditions.
In the scope of this policy, "personal or commercial information" comprises any details that can identify you as an individual or verify your business entity under federal healthcare acts. This includes, but is not limited to, your name, corporate designation, registered pharmacy or hospital name, drug licensing numbers, contact numbers, email coordinates, corporate tax identifiers, and bulk medicine sourcing history.
2. Our Commitment to Privacy & GMP Safeguards
2.1 Data Privacy Principles
As a verified wholesale pharmaceutical trading unit with a legacy of compliant operations since 2015, we are committed to holding your corporate, licensing, and transaction data in absolute confidentiality. We deploy premium electronic security barriers, industrial-grade data encryption (SSL/TLS), and restricted internal access hierarchies to protect your commercial details from unauthorized access, accidental alteration, theft, or regulatory leaks.
We do not lease, trade, or sell our clients' database, contact coordinates, or transaction histories to any third-party marketing brokers. Your distribution requests, custom compound procurements, and pricing inquiries are strictly internal records shared only on a must-know basis with audited logistics partners and drug inspectors.
2.2 Compliance with Drug Regulatory Systems
To adhere to the WHO-GMP (Good Manufacturing Practices) guidelines, Narvs Pharma operates under strict compliance checklists. All transaction documentation, batch record allocations, and chemical verification certifications are cataloged safely. The information relating to manufacturing dates, batch quantities, and target shipping sites is compiled to ensure full tracing records, which is legally accessible only to government authorities or authorized audits upon formal administrative requests.
3. Information We Collect and Process
To facilitate wholesale pharmaceutical transactions and comply with Indian drug regulatory laws, we gather the following forms of data:
- Commercial Inquiry Data: When submitting an inquiry for product procurements (such as Misti XT, Bonrav, Panrav D, or custom formulation licensing) via our communication channels, we collect your name, pharmacy entity, email address, direct contact number, and specific procurement requirements.
- Drug Licensing Verification Details: In accordance with federal laws (including the Drugs and Cosmetics Act, 1940), wholesale pharmaceutical trading requires rigorous credentialing. We collect and archive official copies or numbers of your active **Drug License Form 20 and Form 21**, along with your corporate **Goods and Services Tax (GST) registration** details.
- Technical and Usage Metrics: We automatically capture basic diagnostic data during your visit to narvspharma.com, including your IP address, browser software, referring URLs, operating system metadata, and average interaction times, to refine web layout safety.
- Cookie Management: We utilize subtle cookie identifiers to track website performance and compile aggregate traffic patterns. You can modify your computer browser definitions to reject cookies; however, note that this may limit certain custom functional segments of our digital portals.
4. Third-Party Partners & API Integrations
Our digital platforms may incorporate web API elements, diagnostic trackers, or logistics tracking protocols. When these technical layers interface with partner services (such as certified cold-chain shipping firms, tax audit software, or legal verification servers), we enforce strict data-protection agreements. Any such third-party provider must maintain the same standard of confidentiality, safety, and compliance with Indian healthcare policies as Narvs Pharma.
5. Communications from Narvs Pharma
We utilize your provided corporate communication coordinates (email addresses, phone lines, or business WhatsApp links) strictly for transactional updates, drug recall notices, regulatory updates, freight details, batch releases, and custom manufacturing proposals. We respect your schedule; you may opt out of receiving general informational notices at any point by sending an unsubscribe request to cfanarvs@gmail.com, although critical pharmaceutical compliance notifications will continue to be dispatched as legally required.
6. Platform Access & Minors
[IMPORTANT] Regulatory Limitation: Wholesale pharmaceutical trading, medicine distribution, and commercial procurement portals are strictly restricted to licensed legal businesses, registered pharmacies, hospitals, and medical professionals. We do not knowingly compile records or interact with minors under 18 years of age.
If we discover that an individual under the age of 18 has submitted an inquiry or bypassed verification protocols, we will execute immediate deletions of all associated records from our server storage.
7. Policy Updates & MCA Audits
Narvs Pharma Private Limited is registered with the Ministry of Corporate Affairs, India (MCA) under Corporate Identification Number (CIN) **U74900DL2015PTC277334** and undergoes systematic auditing by the Registrar of Companies (RoC-Delhi). Consequently, this Privacy Policy may be modified periodically to reflect shifting corporate norms, legislative adaptations, or federal drug distribution amendments.
Any revisions to this document take effect immediately upon their public upload to our website. Sourcing operations after policy changes constitute your active acceptance of the revised protocols. In the event of a merger, acquisition, or structural transition of Narvs Pharma, compiled databases will be transferred under strict non-disclosure obligations to the succeeding legal organization.
8. Contact & Compliance Officer
If you have any questions, regulatory requests, data deletion inquiries, or feedback regarding our privacy standards, please get in touch with our commercial relations officer directly: